HFA
Harbert Fund Advisors’s Fennec Pharmaceuticals FENC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Sell |
287,614
-179,255
| -38% | -$1.49M | 7.16% | 6 |
|
|
2025
Q1 | $2.84M | Hold |
466,869
| – | – | 3.22% | 8 |
|
|
2024
Q4 | $2.95M | Hold |
466,869
| – | – | 1.53% | 12 |
|
|
2024
Q3 | $2.33M | Hold |
466,869
| – | – | 1.38% | 20 |
|
|
2024
Q2 | $2.85M | Hold |
466,869
| – | – | 2.03% | 12 |
|
|
2024
Q1 | $5.19M | Hold |
466,869
| – | – | 3.57% | 8 |
|
|
2023
Q4 | $5.24M | Hold |
466,869
| – | – | 3.59% | 8 |
|
|
2023
Q3 | $3.51M | Hold |
466,869
| – | – | 2.5% | 18 |
|
|
2023
Q2 | $4.12M | Hold |
466,869
| – | – | 2.31% | 17 |
|
|
2023
Q1 | $3.88M | Buy |
466,869
+149,920
| +47% | +$1.25M | 2.57% | 11 |
|
|
2022
Q4 | $3.04M | Buy |
316,949
+127,199
| +67% | +$1.22M | 2.44% | 14 |
|
|
2022
Q3 | $1.54M | Hold |
189,750
| – | – | 0.82% | 31 |
|
|
2022
Q2 | $1.06M | Hold |
189,750
| – | – | 0.52% | 27 |
|
|
2022
Q1 | $1.06M | Hold |
189,750
| – | – | 0.45% | 28 |
|
|
2021
Q4 | $835K | Buy |
189,750
+15,000
| +9% | +$66K | 0.21% | 30 |
|
|
2021
Q3 | $1.65M | Buy |
174,750
+53,899
| +45% | +$508K | 0.58% | 23 |
|
|
2021
Q2 | $881K | Buy |
+120,851
| New | +$881K | 0.49% | 27 |
|